StonvexLoading…
StonvexStonvexStonvexCore line items from BIIB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.89B | $9.68B | $9.84B | $10.17B |
Operating Income | $1.56B | $1.91B | $1.30B | $3.59B |
Net Income | $1.29B | $1.63B | $1.16B | $3.05B |
EPS (Diluted) | $8.79 | $11.18 | $7.97 | $20.87 |
Total Assets | $29.44B | $28.05B | $26.84B | $24.55B |
Total Liabilities | $11.18B | $11.33B | $12.05B | $11.17B |
Cash & Equivalents | $3.01B | $2.38B | $1.05B | $3.42B |
Free Cash Flow OCF − CapEx | $2.05B | $2.72B | $1.27B | $1.14B |
Shares Outstanding | 146.80M | 145.80M | 144.90M | 144.00M |